The global Type 2 Diabetes market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.
This report studies the Type 2 Diabetes development status and future trend in China, focuses on top players in China, also splits Type 2 Diabetes by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.
The major players in China market include
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Insulins
DPP-4 inhibitors
GLP-1 receptor agonists
SGLT-2 inhibitors
On the basis of the end users/application, this report covers
Drugstore
Hospital
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
China Type 2 Diabetes Market Research Report 2018
1 Type 2 Diabetes Overview
1.1 Product Overview and Scope of Type 2 Diabetes
1.2 Classification of Type 2 Diabetes by Product Category
1.2.1 China Type 2 Diabetes Sales (K Units) Comparison by Type (2013-2025)
1.2.2 China Type 2 Diabetes Sales (K Units) Market Share by Type in 2017
1.2.3 Insulins
1.2.4 DPP-4 inhibitors
1.2.5 GLP-1 receptor agonists
1.2.6 SGLT-2 inhibitors
1.3 China Type 2 Diabetes Market by Application/End Users
1.3.1 China Type 2 Diabetes Sales (K Units) and Market Share Comparison by Applications (2013-2025)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 China Type 2 Diabetes Market by Region
1.4.1 China Type 2 Diabetes Market Size (Million USD) Comparison by Region (2013-2025)
1.4.2 South China Type 2 Diabetes Status and Prospect (2013-2025)
1.4.3 East China Type 2 Diabetes Status and Prospect (2013-2025)
1.4.4 Southwest China Type 2 Diabetes Status and Prospect (2013-2025)
1.4.5 Northeast China Type 2 Diabetes Status and Prospect (2013-2025)
1.4.6 North China Type 2 Diabetes Status and Prospect (2013-2025)
1.4.7 Central China Type 2 Diabetes Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Type 2 Diabetes (2013-2025)
1.5.1 China Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2025)
1.5.2 China Type 2 Diabetes Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 China Type 2 Diabetes Market Competition by Players/Manufacturers
2.1 China Type 2 Diabetes Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Type 2 Diabetes Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Type 2 Diabetes Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Type 2 Diabetes Market Competitive Situation and Trends
2.4.1 China Type 2 Diabetes Market Concentration Rate
2.4.2 China Type 2 Diabetes Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Type 2 Diabetes Manufacturing Base Distribution, Sales Area, Product Types
3 China Type 2 Diabetes Sales and Revenue by Region (2013-2018)
3.1 China Type 2 Diabetes Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Type 2 Diabetes Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Type 2 Diabetes Price (USD/Unit) by Regions (2013-2018)
4 China Type 2 Diabetes Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Type 2 Diabetes Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Type 2 Diabetes Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Type 2 Diabetes Price (USD/Unit) by Type (2013-2018)
4.4 China Type 2 Diabetes Sales Growth Rate (%) by Type (2013-2018)
5 China Type 2 Diabetes Sales by Application (2013-2018)
5.1 China Type 2 Diabetes Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Type 2 Diabetes Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 China Type 2 Diabetes Players/Suppliers Profiles and Sales Data
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Type 2 Diabetes Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Type 2 Diabetes Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Type 2 Diabetes Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.3.4 Main Business/Business Overview
6.4 Eli Lily
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Type 2 Diabetes Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eli Lily Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Type 2 Diabetes Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.5.4 Main Business/Business Overview
6.6 Astellas Pharma
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Type 2 Diabetes Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Astellas Pharma Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.6.4 Main Business/Business Overview
6.7 Daiichi Sankyo
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Type 2 Diabetes Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Daiichi Sankyo Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.7.4 Main Business/Business Overview
6.8 Biocon
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Type 2 Diabetes Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Biocon Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Type 2 Diabetes Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Boehringer Ingelheim Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
6.9.4 Main Business/Business Overview
7 Type 2 Diabetes Manufacturing Cost Analysis
7.1 Type 2 Diabetes Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Type 2 Diabetes
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Type 2 Diabetes Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Type 2 Diabetes Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Type 2 Diabetes Market Size (Sales and Revenue) Forecast (2018-2025)
11.1 China Type 2 Diabetes Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Type 2 Diabetes Sales (K Units) Forecast by Type (2018-2025)
11.3 China Type 2 Diabetes Sales (K Units) Forecast by Application (2018-2025)
11.4 China Type 2 Diabetes Sales (K Units) Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Type 2 Diabetes Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Type 2 Diabetes Sales (K Units) by Application (2013-2025)
Figure Product Picture of Type 2 Diabetes
Table China Type 2 Diabetes Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Type 2 Diabetes Sales Volume Market Share by Types in 2017
Figure Insulins Product Picture
Figure DPP-4 inhibitors Product Picture
Figure GLP-1 receptor agonists Product Picture
Figure SGLT-2 inhibitors Product Picture
Figure China Type 2 Diabetes Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Type 2 Diabetes by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Type 2 Diabetes Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Type 2 Diabetes Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Type 2 Diabetes Sales of Key Players/Manufacturers (2013-2018)
Table China Type 2 Diabetes Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Type 2 Diabetes Sales Share (%) by Players/Manufacturers
Figure 2017 China Type 2 Diabetes Sales Share (%) by Players/Manufacturers
Table China Type 2 Diabetes Revenue by Players/Manufacturers (2013-2018)
Table China Type 2 Diabetes Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Type 2 Diabetes Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Type 2 Diabetes Revenue Market Share (%) by Players/Manufacturers
Table China Market Type 2 Diabetes Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Type 2 Diabetes Average Price of Key Players/Manufacturers in 2017
Figure China Type 2 Diabetes Market Share of Top 3 Players/Manufacturers
Figure China Type 2 Diabetes Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Type 2 Diabetes Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Type 2 Diabetes Product Category
Table China Type 2 Diabetes Sales (K Units) by Regions (2013-2018)
Table China Type 2 Diabetes Sales Share (%) by Regions (2013-2018)
Figure China Type 2 Diabetes Sales Share (%) by Regions (2013-2018)
Figure China Type 2 Diabetes Sales Market Share (%) by Regions in 2017
Table China Type 2 Diabetes Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Type 2 Diabetes Revenue Market Share (%) by Regions (2013-2018)
Figure China Type 2 Diabetes Revenue Market Share (%) by Regions (2013-2018)
Figure China Type 2 Diabetes Revenue Market Share (%) by Regions in 2017
Table China Type 2 Diabetes Price (USD/Unit) by Regions (2013-2018)
Table China Type 2 Diabetes Sales (K Units) by Type (2013-2018)
Table China Type 2 Diabetes Sales Share (%) by Type (2013-2018)
Figure China Type 2 Diabetes Sales Share (%) by Type (2013-2018)
Figure China Type 2 Diabetes Sales Market Share (%) by Type in 2017
Table China Type 2 Diabetes Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Type 2 Diabetes Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Type 2 Diabetes by Type (2013-2018)
Figure Revenue Market Share of Type 2 Diabetes by Type in 2017
Table China Type 2 Diabetes Price (USD/Unit) by Types (2013-2018)
Figure China Type 2 Diabetes Sales Growth Rate (%) by Type (2013-2018)
Table China Type 2 Diabetes Sales (K Units) by Applications (2013-2018)
Table China Type 2 Diabetes Sales Market Share (%) by Applications (2013-2018)
Figure China Type 2 Diabetes Sales Market Share (%) by Application (2013-2018)
Figure China Type 2 Diabetes Sales Market Share (%) by Application in 2017
Table China Type 2 Diabetes Sales Growth Rate (%) by Application (2013-2018)
Figure China Type 2 Diabetes Sales Growth Rate (%) by Application (2013-2018)
Table Novo Nordisk Type 2 Diabetes Basic Information List
Table Novo Nordisk Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novo Nordisk Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novo Nordisk Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Novo Nordisk Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Sanofi Type 2 Diabetes Basic Information List
Table Sanofi Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Sanofi Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Merck Type 2 Diabetes Basic Information List
Table Merck Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Merck Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Merck Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Merck Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Eli Lily Type 2 Diabetes Basic Information List
Table Eli Lily Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eli Lily Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eli Lily Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Eli Lily Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table AstraZeneca Type 2 Diabetes Basic Information List
Table AstraZeneca Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure AstraZeneca Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Astellas Pharma Type 2 Diabetes Basic Information List
Table Astellas Pharma Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Astellas Pharma Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Astellas Pharma Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Astellas Pharma Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Daiichi Sankyo Type 2 Diabetes Basic Information List
Table Daiichi Sankyo Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Daiichi Sankyo Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Daiichi Sankyo Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Biocon Type 2 Diabetes Basic Information List
Table Biocon Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Biocon Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Biocon Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Biocon Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Boehringer Ingelheim Type 2 Diabetes Basic Information List
Table Boehringer Ingelheim Type 2 Diabetes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim Type 2 Diabetes Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Boehringer Ingelheim Type 2 Diabetes Sales Market Share (%) in China (2013-2018)
Figure Boehringer Ingelheim Type 2 Diabetes Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Type 2 Diabetes
Figure Manufacturing Process Analysis of Type 2 Diabetes
Figure Type 2 Diabetes Industrial Chain Analysis
Table Raw Materials Sources of Type 2 Diabetes Major Players/Manufacturers in 2017
Table Major Buyers of Type 2 Diabetes
Table Distributors/Traders List
Figure China Type 2 Diabetes Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Type 2 Diabetes Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Type 2 Diabetes Price (USD/Unit) Trend Forecast (2018-2025)
Table China Type 2 Diabetes Sales (K Units) Forecast by Type (2018-2025)
Figure China Type 2 Diabetes Sales (K Units) Forecast by Type (2018-2025)
Figure China Type 2 Diabetes Sales Volume Market Share Forecast by Type in 2025
Table China Type 2 Diabetes Sales (K Units) Forecast by Application (2018-2025)
Figure China Type 2 Diabetes Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Type 2 Diabetes Sales Volume Market Share Forecast by Application in 2025
Table China Type 2 Diabetes Sales (K Units) Forecast by Regions (2018-2025)
Table China Type 2 Diabetes Sales Volume Share Forecast by Regions (2018-2025)
Figure China Type 2 Diabetes Sales Volume Share Forecast by Regions (2018-2025)
Figure China Type 2 Diabetes Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
